Article info

Download PDFPDF

617 Trastuzumab and pertuzumab combination therapy activates complement-dependent cytotoxicity and phagocytosis against HER2+ breast cancer
Free

Authors

Citation

Tsao L, Hartman Z
617 Trastuzumab and pertuzumab combination therapy activates complement-dependent cytotoxicity and phagocytosis against HER2+ breast cancer

Publication history

  • First published November 10, 2021.
Online issue publication 
November 10, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.